232 related articles for article (PubMed ID: 15703296)
21. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
22. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
[TBL] [Abstract][Full Text] [Related]
23. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
Guggino WB; Cebotaru L
Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
[TBL] [Abstract][Full Text] [Related]
24. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.
Johnson LG; Pickles RJ; Boyles SE; Morris JC; Ye H; Zhou Z; Olsen JC; Boucher RC
Hum Gene Ther; 1996 Jan; 7(1):51-9. PubMed ID: 8825868
[TBL] [Abstract][Full Text] [Related]
25. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.
Lei DC; Kunzelmann K; Koslowsky T; Yezzi MJ; Escobar LC; Xu Z; Ellison AR; Rommens JM; Tsui L-C ; Tykocinski M; Gruenert DC
Gene Ther; 1996 May; 3(5):427-36. PubMed ID: 9156804
[TBL] [Abstract][Full Text] [Related]
26. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
[TBL] [Abstract][Full Text] [Related]
27. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
29. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
[TBL] [Abstract][Full Text] [Related]
30. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
[TBL] [Abstract][Full Text] [Related]
31. Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates.
Fischer AC; Smith CI; Cebotaru L; Zhang X; Askin FB; Wright J; Guggino SE; Adams RJ; Flotte T; Guggino WB
Mol Ther; 2007 Apr; 15(4):756-63. PubMed ID: 17299412
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
Dong JY; Fan PD; Frizzell RA
Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
[TBL] [Abstract][Full Text] [Related]
34. Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance.
Itani OA; Chen JH; Karp PH; Ernst S; Keshavjee S; Parekh K; Klesney-Tait J; Zabner J; Welsh MJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10260-5. PubMed ID: 21646513
[TBL] [Abstract][Full Text] [Related]
35. A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia.
Yan Z; Keiser NW; Song Y; Deng X; Cheng F; Qiu J; Engelhardt JF
Mol Ther; 2013 Dec; 21(12):2181-94. PubMed ID: 23896725
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
37. Polarized AAVR expression determines infectivity by AAV gene therapy vectors.
Hamilton BA; Li X; Pezzulo AA; Abou Alaiwa MH; Zabner J
Gene Ther; 2019 Jun; 26(6):240-249. PubMed ID: 30962536
[TBL] [Abstract][Full Text] [Related]
38. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
39. Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction.
Liu X; Yan Z; Luo M; Engelhardt JF
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):56-64. PubMed ID: 16195538
[TBL] [Abstract][Full Text] [Related]
40. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
